Mum's hay fever symptoms lead to 'one in a million' cancer diagnosis
Ms Wellings symptoms first appeared during the Covid-19 pandemic but she initially dismissed it as allergies, despite never having suffered from hay fever."I'd had no pain, just runny eyes, runny nose, sneezing and eventually a nosebleed," she said."It came as such a shock to be told I had cancer, let alone one so rare."Ms Wellings underwent several surgeries to remove the tumours but they soon returned, fusing her eyeball to the surrounding bone."The only way we could eradicate and control my disease was to lose my eye, but I was willing to do that just to live," she said.Surgeons took several skin grafts and veins from her arm to rebuild her face. But the grafts did not take, meaning she was left with a permanent hole where her eye socket is.However, her latest scans show the cancer is stable.
Ms Wellings is now backing a call from Cancer Research UK for people to leave a gift to the charity in their will.The Gifts in Wills scheme funds a third of the charity's work, which has helped double cancer survival in the UK by investing in pioneering trials and research."Advances in research mean people are being diagnosed earlier, have access to kinder and more effective treatments, and some cancers are prevented completely," Ms Wellings said."People could help give the gift of hope to many more people like me."
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Metro
23 minutes ago
- Metro
Anne Nolan, 74, emotional about 'sisters who didn't survive'
To view this video please enable JavaScript, and consider upgrading to a web browser that supports HTML5 video Anne Nolan has spoken about losing her late sisters as she opens up about becoming cancer-free. Appearing on Good Morning Britain on Monday morning, Anne shared the exciting news that she is officially cancer-free after being diagnosed with breast cancer for the second time in 2020. The former singer from The Nolans told Ed Balls and Charlotte Hawkins that after hearing the good news, she immediately thought of her sisters who had died. Linda Nolan died in January at the age of 65, and Bernie Nolan died in 2013 at the age of 52, both from breast cancer. 'It's been very traumatic. When I received the letter a few weeks ago, I picked it up, and it said NHS, and I thought, 'Oh I don't want to know, I'm not sure if I want to know if it's bad news'. 'And I put it aside for about ten minutes, and after a while, my logical brain kicked in and said, 'You have to find out, you need to know. 'I opened it and it was all good news, and I had a bit of a weep at the beginning. I feel lucky, blessed, relieved, and then emotional thinking about my sisters having gone through the same thing but not surviving.' She then spoke about her own cancer journey, which has been going on for five years. 'I rang the bell five years ago after I finished my chemo, but then you have another five years before you're actually told that the cancer is no, it hasn't come back. 'Yeah, I had a mammogram every year for five years, and the last one was in May this year. But I did think about Linda at the time and Bernie as well. Bernie is like Bernie has been gone now about 12 years. She added that she's sure Linda is looking down on her, thinking 'thank goodness.' She reflected that although she and Linda had been diagnosed with cancer around the same time, Linda did not survive the ordeal. 'Linda received her diagnosis about a week after me, actually, and we went through it together during Covid.' She then reminisced on this time together: 'Linda and I were there to support each other. We had our chemo together. She was the one who called us the chemo sisters. She was always in a good mood, always happy and kept me going because I had, I had a bad time during my chemo, and it was great to have her support. 'And then when her cancer spread, she didn't survive.' This interview comes after the star announced the news publicly just a few days ago. On social media, she shared a long message with fans: 'Now, five years later, I'm overjoyed to share that my latest results show I am cancer free.' In an interview with The Mirror, she shared that she immediately thought of her sisters who had died from cancer. More Trending 'Although I was absolutely thrilled, I did think about them,' she said. 'I didn't feel guilty because it's nothing to do with me but I did feel sad that they weren't as lucky as I was. It's an emotional thing for me to think about them not surviving and then I did survive. But that's just the luck of the draw.' She added that she now is ready to seize life and 'grab everything with both hands.' 'When you've had a life-threatening disease and you've lost two sisters then it brings it all to the forefront,' she said. 'It makes you value life. You grab everything with both hands. Whenever I'm asked to do something, I say yes straight away. When you come through it and you're at the other end and you think, well I didn't die and I'm alive and I'm gonna live every day.' Got a story? If you've got a celebrity story, video or pictures get in touch with the entertainment team by emailing us celebtips@ calling 020 3615 2145 or by visiting our Submit Stuff page – we'd love to hear from you. View More » MORE: I had a Commodore Amiga as a kid and this is not the gaming future I imagined – Reader's Feature MORE: Legendary TV star 'helps police arrest real-life criminal' MORE: Lego Game Boy is so accurate even the advert is the same
Daily Record
2 hours ago
- Daily Record
'I thought snoring was a blocked nose - it was sign of skull-eroding disease'
Claire Barbery, 51, began snoring at night after experiencing a continuous blockage in one side of her nose - and almost cancelled her hospital appointment A mum who started snoring in her sleep after developing a blocked nose was stunned to discover her single symptom was actually a sign of rare cancer. Claire Barbery, 51, almost cancelled the hospital appointment that led to her diagnosis because she didn't want to "waste the time" of the NHS. She began experiencing a persistent blockage in one side of her nose but initially put it down to the effects of regular Covid testing while working in a care home. Claire also started snoring in her sleep for the first time and decided to get medical help after using a steroid spray without any improvement in January 2023. She was referred to an ENT specialist and following scans and a biopsy, doctors broke the devastating news that she had olfactory neuroblastoma – a rare cancer that develops in the upper part of the nasal cavity. The 5cm tumour had already started eroding bone at the base of her skull and she underwent complex surgery to have it removed at Birmingham's Queen Elizabeth Hospital. Claire, from Newquay, Cornwall, is now urging others to seek medical advice for persistent symptoms, no matter how trivial they may seem. She said: "I very nearly cancelled that appointment because I didn't want to be wasting NHS time. There's nothing wrong, I thought. But looking back, that decision could have cost me my life. "I started snoring, which I'd never done before. I was waking myself up, breathing through my mouth rather than my nose. Even then, I nearly cancelled my hospital appointment. I didn't want to waste anyone's time I just left it and thought it was something to do with having had COVID the month before." Claire has now teamed up with UK charity Get A-Head Charitable Trust to boost awareness of World Head and Neck Cancer Day. She added: "If you know your body, then you've got to push. If there's something wrong, don't ignore it." The operation in January last year was carried out by consultant surgeon Shahz Ahmed, who specialises in skull base procedures. It was captured as part of the Channel 5 documentary 'Surgeons: A Matter of Life or Death'. Mr Ahmed said: "Claire had a very rare form of cancer that needed to be removed. Untreated, it could have metastasized and spread into the neck and the rest of the body. It had already gone through the skull base into the base of the brain and if left, it would have become harder and harder to treat." The intricate operation involved extracting the tumour, along with Claire's olfactory bulbs – meaning she has permanently lost her sense of smell – and rebuilding the area between her nose and brain. Mr Ahmed added: "The key worries were operating between the left and the right eye. The main blood supply to the brain is in very close proximity so the risk of seizures, stroke, injury to the brain and loss of life, were all very real. Thankfully, the surgery was a huge success and Claire suffered no complications." After her operation, Claire endured six weeks of chemotherapy and radiotherapy and is now regularly reviewed by her medical team. She's slowly getting back to work and since her treatment ended, she's been enjoying holidays with her husband Gary and spending more time with her daughters Lowenna, 27, and Keizha, 25.
Times
9 hours ago
- Times
Scientists' discovery could stop breast cancer spreading
Scottish scientists have made a discovery that could help stop breast cancer spreading to other parts of the body. Experts at Cancer Research UK Scotland Institute and the University of Glasgow have found there are key metabolic changes that take place before tumours grow elsewhere. Their work is being hailed as a significant breakthrough because it is often cancer moving from the breast that kills patients. • How I told my sons that I had a rare form of breast cancer Researchers writing in the journal EMBO Reports said identifying the metabolic changes offered a vital window to intervene. Detecting these changes early could allow therapies to stop cancer cells moving around the body and forming tumours elsewhere. Dr Cassie Clarke, lead researcher, said: 'This study represents a major shift in how we think about preventing the spread of breast cancer. By targeting these metabolic changes as early as possible we could stop the cancer progressing and save lives.' About 56,800 people are diagnosed with breast cancer in the United Kingdom each year and 11,300 people lose their lives to the disease. Dr Catherine Elliott, Cancer Research UK's director of research, said: 'Discoveries in cancer research have made huge strides in making breast cancer a far more treatable disease than ever before. • Why the way we diagnose, label and treat cancer is changing 'However, metastasis — when cancer spreads — is a major factor in breast cancer becoming harder to treat, especially if the cancer returns months or even many years later. 'This discovery gives us new hope for detecting and stopping metastasis early and ensuring people have many more years with their families and loved ones.' The study focused on how breast cancer changes the immune system so it cannot tackle cancer cells as they begin their spread. The researchers found that cancer changes the metabolism — the way cells make and use energy — of specific immune cells, resulting in them releasing a prominent metabolite called uracil. Uracil is a molecule key to essential processes in the body which was found to help distant organs build a 'scaffold' to grow secondary tumours elsewhere in the body. By blocking an enzyme called uridine phosphorylase-1 (UPP1), which produces uracil, the scientists were able to stop this scaffold forming in mice and restore the ability of the immune system to kill secondary cancer cells to prevent metastasis. This opens the door to potentially powerful new tools to tackle cancer. Detecting uracil in the blood could help spot early signs of cancer spread, while blocking UPP1 with drugs could stop the spread before it starts. • The Times View: It is time to be optimistic about cancer The research was funded by Cancer Research UK, the Wellcome Trust, the Medical Research Council, Breast Cancer Now and Pancreatic Cancer UK. Simon Vincent, chief scientific officer at Breast Cancer Now, said: 'The researchers discovered that high levels of a protein called UPP1 may make some cancers, including breast cancer, more likely to spread to other parts of the body, where the disease becomes incurable. 'In mice, targeting the UPP1 protein before secondary breast cancer developed led to fewer secondary breast tumours and a boosted immune response in the lungs. 'Now we need more research to see if this new insight can be turned into new drugs that stop secondary breast cancer, and potentially other secondary cancers, in their tracks. With around 61,000 people living with secondary breast cancer in the UK, research like this is vital.' The team are further investigating exactly how UPP1 changes the behaviour of immune cells, exploring the role of immune cell metabolism in early breast cancer initiation, and testing the ability of drugs that block immune cell metabolism to prevent cancer occurring.
